Shortness Of Breath in Lung Cancer

Not Applicable

Completed

• Conditions: Cancer; Intrathoracic cancer

• Registration Number: ISRCTN49387307
• Lead Sponsor: Hull and East Yorkshire Hospitals NHS Trust (HEYHT) (UK)

Brief Summary

2014 Results article in https://doi.org/10.1200/jco.2014.32.31_suppl.54 cost-effectiveness results 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26345362 results

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-01-25
• Study Completion: 2013-03-31
• Last Update Posted: 7 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 156

Inclusion Criteria

1. Primary or secondary malignant lung disease
2. Aged over 18 years
3. Willingness to engage with breathlessness training
4. Ability to give informed consent
5. Sufficient understanding of the English language to complete the study questionnaires
6. Severity average breathlessness (Numeric Rating Scale [NRS]) greater than 3
7. All identified reversible causes of the breathlessness have been treated if appropriate to do so, in the opinion of the attending clinician
8. Verbal confirmation of consent
9. Estimated prognosis (in the investigator's opinion) of greater than 3 months

Exclusion Criteria

1. Inability to give informed consent
2. Intercurrent illness or co-morbidities making completion of the study unlikely
3. Rapidly worsening breathlessness requiring urgent medical intervention
4. Insufficient understanding of the English language to complete the study questionnaires
5. Verbal withdrawal of consent
6. Unable to complete study assessments

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Worst severity of breathlessness over past 24 hours measured by NRS